Mechanisms underlying the autonomic modulation of ventricular fibrillation initiation—tentative prophylactic properties of vagus nerve stimulation on malignant arrhythmias in heart failure
暂无分享,去创建一个
James Winter | G. Ng | Kieran E. Brack | G. André Ng | K. Brack | J. Winter
[1] J. Coote,et al. Direct evidence of nitric oxide release from neuronal nitric oxide synthase activation in the left ventricle as a result of cervical vagus nerve stimulation , 2009, The Journal of physiology.
[2] M. Sugimachi,et al. Vagal stimulation markedly suppresses arrhythmias in conscious rats with chronic heart failure after myocardial infarction , 2005, 2005 IEEE Engineering in Medicine and Biology 27th Annual Conference.
[3] K. Umeno,et al. Time course of sympathovagal imbalance and left ventricular dysfunction in conscious dogs with heart failure. , 1998, Journal of applied physiology.
[4] Nicola Montano,et al. Respiratory-related heart rate variability in progressive experimental heart failure. , 2005, American journal of physiology. Heart and circulatory physiology.
[5] J. Balligand,et al. Nitric Oxide and Cardiac Function: Ten Years After, and Continuing , 2003, Circulation research.
[6] D. Chialvo,et al. Electrical Restitution, Critical Mass, and the Riddle of Fibrillation , 1999, Journal of cardiovascular electrophysiology.
[7] M. N. Levy,et al. Sinus and atrioventricular nodal distribution of sympathetic fibers that contain neuropeptide Y. , 1990, Circulation research.
[8] M. N. Levy,et al. Inhibition of Cardiac Vagal Effects by Neurally Released and Exogenous Neuropeptide Y , 1989, Circulation research.
[9] Kapil Kumar,et al. Potent antifibrillatory effects of intrapericardial nitroglycerin in the ischemic porcine heart. , 2003, Journal of the American College of Cardiology.
[10] J. Papp,et al. Electrophysiological effects of ivabradine in dog and human cardiac preparations: potential antiarrhythmic actions. , 2011, European journal of pharmacology.
[11] L. Rohde,et al. Cholinergic stimulation with pyridostigmine reduces ventricular arrhythmia and enhances heart rate variability in heart failure. , 2003, American heart journal.
[12] H. L. Stone,et al. Autonomic mechanisms in ventricular fibrillation induced by myocardial ischemia during exercise in dogs with healed myocardial infarction. An experimental preparation for sudden cardiac death. , 1984, Circulation.
[13] A. Camm,et al. Risk stratification for arrhythmic events in postinfarction patients based on heart rate variability, ambulatory electrocardiographic variables and the signal-averaged electrocardiogram. , 1991, Journal of the American College of Cardiology.
[14] S. Epstein,et al. Influence of Atropine and of Vagally Mediated Bradycardia on the Occurrence of Ventricular Arrhythmias following Acute Coronary Occlusion in Closed‐Chest Dogs , 1973, Circulation.
[15] M. N. Levy,et al. Neuropeptide Y as a Putative Modulator of the Vagal Effects on Heart Rate , 1989, Circulation research.
[16] S. Priori,et al. Protective Effect of Vagal Stimulation on Reperfusion Arrhythmias in Cats , 1987, Circulation research.
[17] Y. H. Zhang,et al. Suppressing sympathetic activation with clonidine on ventricular arrhythmias in congestive heart failure. , 1998, International journal of cardiology.
[18] P. Schwartz,et al. Baroreflex sensitivity, clinical correlates, and cardiovascular mortality among patients with a first myocardial infarction. A prospective study. , 1988, Circulation.
[19] S. S. Hull,et al. Vagal reflexes and survival during acute myocardial ischemia in conscious dogs with healed myocardial infarction. , 1991, The American journal of physiology.
[20] J. Coote,et al. Differential cardiac responses to unilateral sympathetic nerve stimulation in the isolated innervated rabbit heart , 2012, Autonomic Neuroscience.
[21] Y. Furukawa,et al. Cardiac responses to VIP and VIP-ergic-cholinergic interaction in isolated dog heart preparations. , 1990, European journal of pharmacology.
[22] A J Camm,et al. Prognostic value of baroreflex sensitivity testing after acute myocardial infarction. , 1992, British heart journal.
[23] M. Dunlap,et al. Evidence for impaired vagus nerve activity in heart failure , 2011, Heart Failure Reviews.
[24] E. Potter. Neuropeptide Y as an autonomic neurotransmitter. , 1988, Pharmacology & therapeutics.
[25] J. Nolasco,et al. A graphic method for the study of alternation in cardiac action potentials. , 1968, Journal of applied physiology.
[26] D. Paterson,et al. Pre-synaptic NO-cGMP pathway modulates vagal control of heart rate in isolated adult guinea pig atria. , 2000, Journal of molecular and cellular cardiology.
[27] R Dietz,et al. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group. , 2000, JAMA.
[28] J. Wess,et al. M2 and M4 Receptor Knockout Mice: Muscarinic Receptor Function in Cardiac and Smooth Muscle In Vitro , 2000 .
[29] A. Feldman,et al. Morphological and functional changes in cardiac myocytes isolated from mice overexpressing TNF-alpha. , 2003, American journal of physiology. Heart and circulatory physiology.
[30] J. Jalife,et al. Morphologic pattern of the intrinsic ganglionated nerve plexus in mouse heart. , 2011, Heart rhythm.
[31] D. Corrado,et al. Sudden cardiac death in young people with apparently normal heart. , 2001, Cardiovascular research.
[32] K. Kent,et al. Electrical Stability of Acutely Ischemic Myocardium: Influences of Heart Rate and Vagal Stimulation , 1973, Circulation.
[33] A. Samaan. The antagonistic cardiac nerves and heart rate. , 2022, Journal of Physiology.
[34] P. Schwartz,et al. The autonomic nervous system and sudden death. , 1998, European heart journal.
[35] S. Dhein,et al. Muscarinic receptors in the mammalian heart. , 2001, Pharmacological research.
[36] J. Coote,et al. Autonomic modulation of electrical restitution, alternans and ventricular fibrillation initiation in the isolated heart. , 2007, Cardiovascular research.
[37] S Capewell,et al. Decreased cardiac parasympathetic activity in chronic heart failure and its relation to left ventricular function. , 1992, British heart journal.
[38] F. X. Guix,et al. The physiology and pathophysiology of nitric oxide in the brain , 2005, Progress in Neurobiology.
[39] M. N. Levy,et al. Effect of Enhanced Contractility on the Left Ventricular Response to Vagus Nerve Stimulation in Dogs , 1969, Circulation research.
[40] E. Vester,et al. Entzündung des Myokards als Arrhythmietrigger , 2000, Zeitschrift für Kardiologie.
[41] A Garfinkel,et al. Ventricular Fibrillation: How Do We Stop the Waves From Breaking? , 2000, Circulation research.
[42] G. Mancia,et al. Sympathetic and reflex abnormalities in heart failure secondary to ischaemic or idiopathic dilated cardiomyopathy. , 2001, Clinical science.
[43] D. Paterson,et al. Neuropeptide Y reduces acetylcholine release and vagal bradycardia via a Y2 receptor-mediated, protein kinase C-dependent pathway. , 2008, Journal of molecular and cellular cardiology.
[44] S. Moncada,et al. Nitric oxide: physiology, pathophysiology, and pharmacology. , 1991, Pharmacological reviews.
[45] M. Caron,et al. Beta-adrenergic receptors: biochemical mechanisms of physiological regulation. , 1984, Physiological reviews.
[46] Kevin J. Tracey,et al. The inflammatory reflex , 2002, Nature.
[47] J. Balligand,et al. Nitric oxide and cardiac function. , 1996, Circulation research.
[48] D. Pauza,et al. Morphology of the Intrinsic Cardiac Nervous System in the Dog: A Whole-Mount Study Employing Histochemical Staining with Acetylcholinesterase , 2003, Cells Tissues Organs.
[49] P. Schauerte,et al. Epicardial neural ganglionated plexus of ovine heart: anatomic basis for experimental cardiac electrophysiology and nerve protective cardiac surgery. , 2010, Heart rhythm.
[50] J. Brown,et al. Presynaptic modulation of acetylcholine release from cardiac parasympathetic neurons. , 1985, The American journal of physiology.
[51] R. J. Harman,et al. National Institute for clinical excellence preoperative tests: Is the consensus hard to get?: 1AP3-9 , 2007 .
[52] P. Schwartz,et al. Single cardiac vagal fiber activity, acute myocardial ischemia, and risk for sudden death. , 1991, Circulation research.
[53] D. Pauza,et al. Architecture and age-related analysis of the neuronal number of the guinea pig intrinsic cardiac nerve plexus. , 2005, Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft.
[54] J. Coote,et al. Nitric oxide mediates the vagal protective effect on ventricular fibrillation via effects on action potential duration restitution in the rabbit heart , 2007, The Journal of physiology.
[55] N. Westerhof,et al. Nitric oxide and cardiac function. , 2007, Life sciences.
[56] J. Coote,et al. Vagus nerve stimulation protects against ventricular fibrillation independent of muscarinic receptor activation. , 2011, Cardiovascular research.
[57] P. Pagé,et al. Localization of multiple neurotransmitters in surgically derived specimens of human atrial ganglia , 2009, Neuroscience.
[58] K. Muramoto,et al. Efferent Vagal Nerve Stimulation Protects Heart Against Ischemia-Induced Arrhythmias by Preserving Connexin43 Protein , 2005, Circulation.
[59] R. Baisden,et al. Localization of muscarinic receptor mRNAs in rat heart and intrinsic cardiac ganglia by in situ hybridization. , 1994, Circulation research.
[60] G. Salama,et al. Autonomic Nerve Stimulation Reverses Ventricular Repolarization Sequence in Rabbit Hearts , 2007, Circulation research.
[61] J. Fleiss,et al. Frequency Domain Measures of Heart Period Variability and Mortality After Myocardial Infarction , 1992, Circulation.
[62] H. Sabbah,et al. 744 Long-term therapy with neuroselective electric Vagus nerve stimulation improves LV function and attenuates global LV remodelling in dogs with chronic heart failure , 2005 .
[63] J. Han,et al. Effects of vagal stimulation, atropine, and propranolol on fibrillation threshold of normal and ischemic ventricles. , 1977, American Heart Journal.
[64] G. Salama,et al. Electrical remodeling of cardiac myocytes from mice with heart failure due to the overexpression of tumor necrosis factor-alpha. , 2006, American journal of physiology. Heart and circulatory physiology.
[65] M. N. Levy,et al. Effect of Vagal Stimulation on the Overflow of Norepinephrine into the Coronary Sinus during Cardiac Sympathetic Nerve Stimulation in the Dog , 1976, Circulation research.
[66] N. B. Strydom,et al. The influence of boot weight on the energy expenditure of men walking on a treadmill and climbing steps , 2004, Internationale Zeitschrift für angewandte Physiologie einschließlich Arbeitsphysiologie.
[67] S. Weidmann,et al. The electrical constants of Purkinje fibres , 1952, The Journal of physiology.
[68] Yanjie Lu,et al. Choline produces antiarrhythmic actions in animal models by cardiac M3 receptors: improvement of intracellular Ca2+ handling as a common mechanism. , 2008, Canadian journal of physiology and pharmacology.
[69] P. Corr,et al. Role of the Vagus Nerves in the Cardiovascular Changes Induced by Coronary Occlusion , 1974, Circulation.
[70] C. Kidd,et al. Neuronal nitric oxide facilitates vagal chronotropic and dromotropic actions on the heart. , 1999, Journal of the autonomic nervous system.
[71] K. Yano,et al. Histological study on the distribution of autonomic nerves in the human heart , 2003, Heart and Vessels.
[72] Bramahn . Singh,et al. Controlling Cardiac Arrhythmias by Lengthening Repolarization: Rationale from Experimental Findings and Clinical Considerations a , 1992, Annals of the New York Academy of Sciences.
[73] Roberto Maestri,et al. Prognostic implications of baroreflex sensitivity in heart failure patients in the beta-blocking era. , 2009, Journal of the American College of Cardiology.
[74] S. Snyder,et al. Interaction between neuronal nitric oxide synthase and inhibitory G protein activity in heart rate regulation in conscious mice. , 1998, The Journal of clinical investigation.
[75] A Garfinkel,et al. Spatiotemporal heterogeneity in the induction of ventricular fibrillation by rapid pacing: importance of cardiac restitution properties. , 1999, Circulation research.
[76] Zoran B. Popović,et al. Chronic Vagus Nerve Stimulation Improves Autonomic Control and Attenuates Systemic Inflammation and Heart Failure Progression in a Canine High-Rate Pacing Model , 2009, Circulation. Heart failure.
[77] A. Gerdes,et al. Chronic pressure overload cardiac hypertrophy and failure in guinea pigs: III. Intercalated disc remodeling. , 1999, Journal of molecular and cellular cardiology.
[78] K. Malik,et al. Effect of M2 muscarinic receptor antagonist 4-DAMP, on prostaglandin synthesis and mechanical function in the isolated rabbit heart. , 1989, General pharmacology.
[79] G. Bricca,et al. Ivabradine Induces an Increase in Ventricular Fibrillation Threshold During Acute Myocardial Ischemia: An Experimental Study , 2008, Journal of cardiovascular pharmacology.
[80] Hui-zhen Wang,et al. M3-R/IK(M3)--a new target of antiarrhythmic agents. , 2005, Yao xue xue bao = Acta pharmaceutica Sinica.
[81] A. Samaan. The antagonistic cardiac nerves and heart rate 1 , 1935 .
[82] H. Crijns,et al. Heart rate variability in left ventricular dysfunction and heart failure: effects and implications of drug treatment. , 1994, British heart journal.
[83] R. Gilmour,et al. Electrical restitution and spatiotemporal organization during ventricular fibrillation. , 1999, Circulation research.
[84] B. Surawicz,et al. Characteristics and Possible Mechanism of Ventricular Arrhythmia Dependent on the Dispersion of Action Potential Durations , 1983, Circulation.
[85] R. Marshall,et al. Effects of antiarrhythmic drugs on ventricular fibrillation thresholds of normal and ischaemic myocardium in the anaesthetized rat , 1983, British journal of pharmacology.
[86] J. Jalife,et al. Immunohistochemical characterization of the intrinsic cardiac neural plexus in whole-mount mouse heart preparations. , 2011, Heart rhythm.
[87] J. Coote,et al. Interaction between direct sympathetic and vagus nerve stimulation on heart rate in the isolated rabbit heart , 2004, Experimental physiology.
[88] I. Zucker,et al. Central gain of the cardiac sympathetic afferent reflex in dogs with heart failure. , 1997, The American journal of physiology.
[89] T. LeJemtel,et al. High prevalence of nonsustained ventricular tachycardia in severe congestive heart failure. , 1984, American heart journal.
[90] Chaoqian Xu,et al. Overexpression of M3 Muscarinic Receptor Is a Novel Strategy for Preventing Sudden Cardiac Death in Transgenic Mice , 2011, Molecular medicine.
[91] V. Shusterman,et al. Calcium-dependent arrhythmias in transgenic mice with heart failure. , 2003, American journal of physiology. Heart and circulatory physiology.
[92] D. Pauza,et al. Morphology, distribution, and variability of the epicardiac neural ganglionated subplexuses in the human heart , 2000, The Anatomical record.
[93] J. Coote,et al. Vagus nerve stimulation inhibits the increase in Ca2+ transient and left ventricular force caused by sympathetic nerve stimulation but has no direct effects alone – epicardial Ca2+ fluorescence studies using fura‐2 AM in the isolated innervated beating rabbit heart , 2010, Experimental physiology.
[94] J. Coote,et al. Effects of Direct Sympathetic and Vagus Nerve Stimulation on the Physiology of the Whole Heart – A Novel Model of Isolated Langendorff Perfused Rabbit Heart with Intact Dual Autonomic Innervation , 2001, Experimental physiology.
[95] A. Garfinkel,et al. Preventing ventricular fibrillation by flattening cardiac restitution. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[96] B. Olshansky,et al. Inflammatory cytokines and nitric oxide in heart failure and potential modulation by vagus nerve stimulation , 2011, Heart Failure Reviews.
[97] T. Gray,et al. Nitric oxide and carbon monoxide synthesizing enzymes and soluble guanylyl cyclase within neurons of adult human cardiac ganglia , 2009, Autonomic Neuroscience.
[98] R. Hershberger,et al. Effect of Vasoactive Intestinal Peptide on Myocardial Contractility and Coronary Blood Flow in the Dog: Comparison with Isoproterenol and Forskolin , 1988, Journal of cardiovascular pharmacology.
[99] S. Chugh,et al. Sudden cardiac death with apparently normal heart. , 2000, Circulation.
[100] W. C. Randall,et al. Selective vagal innervation of sinoatrial and atrioventricular nodes in canine heart. , 1986, The American journal of physiology.
[101] M. Beckmann,et al. [Inflammation of the myocardium as an arrhythmia trigger]. , 2000, Zeitschrift fur Kardiologie.
[102] D. Zipes,et al. Effects of Sympathetic and Vagal Nerves on Recovery Properties of the Endocardium and Epicardium of the Canine Left Ventricle , 1980, Circulation research.
[103] D. Schulze,et al. Muscarinic Modulation of the Sodium-Calcium Exchanger in Heart Failure , 2007, Circulation.
[104] J. Brown,et al. Acetylcholine release from rat atria can be regulated through an alpha 1-adrenergic receptor. , 1985, Circulation research.
[105] J. A. Armour,et al. Potential clinical relevance of the ‘little brain’ on the mammalian heart , 2008, Experimental physiology.
[106] H. Bruck,et al. Presence, distribution and physiological function of adrenergic and muscarinic receptor subtypes in the human heart , 2001, Basic Research in Cardiology.
[107] Peter J. Schwartz,et al. Vagus nerve stimulation: from pre-clinical to clinical application: challenges and future directions , 2011, Heart Failure Reviews.
[108] M. Josephson,et al. Termination of Ventricular Tachycardia with Ventricular Stimulation: Salutary Effect of Increased Current Strength , 1982, Circulation.
[109] Philip J Podrid,et al. Epidemiology and stratification of risk for sudden cardiac death , 2005, Clinical cardiology.
[110] J. Miller,et al. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. , 1987, The American journal of cardiology.
[111] Chao Wang,et al. Activation of cardiac M3 muscarinic acetylcholine receptors has cardioprotective effects against ischaemia‐induced arrhythmias , 2012, Clinical and experimental pharmacology & physiology.
[112] S. S. Hull,et al. Vagal stimulation and prevention of sudden death in conscious dogs with a healed myocardial infarction. , 1991, Circulation research.
[113] E. Muscholl. Peripheral muscarinic control of norepinephrine release in the cardiovascular system. , 1980, The American journal of physiology.
[114] M. N. Levy,et al. Sympathetic stimulation-evoked overflow of norepinephrine and neuropeptide Y from the heart. , 1991, Circulation research.
[115] Takeshi Tsutsumi,et al. Classification of antiarrhythmic drugs based on ventricular fibrillation threshold. , 1989, The American journal of cardiology.
[116] A. Karma. Electrical alternans and spiral wave breakup in cardiac tissue. , 1994, Chaos.
[117] P. Schwartz,et al. Autonomic mechanisms and sudden death. New insights from analysis of baroreceptor reflexes in conscious dogs with and without a myocardial infarction. , 1988, Circulation.
[118] J. Armour. Instant to Instant Reflex Cardiac Regulation , 1976 .
[119] D. Rosenbaum,et al. Modulated dispersion explains changes in arrhythmia vulnerability during premature stimulation of the heart. , 1998, Circulation.
[120] R. Helfant,et al. Electrophysiology underlying ventricular arrhythmias due to coronary ligation. , 1970, The American journal of physiology.
[121] J. Lauenstein,et al. Parasympathetic control of the heart. I. An interventriculo-septal ganglion is the major source of the vagal intracardiac innervation of the ventricles. , 2004, Journal of applied physiology.
[122] A. Pearlman,et al. Beneficial Effects of Vagal Stimulation and Bradycardia During Experimental Acute Myocardial Ischemia , 1974, Circulation.
[123] I. Zucker,et al. Enhanced activity of carotid body chemoreceptors in rabbits with heart failure: role of nitric oxide. , 1999, Journal of applied physiology.
[124] Masaru Sugimachi,et al. Vagal Nerve Stimulation Markedly Improves Long-Term Survival After Chronic Heart Failure in Rats , 2003, Circulation.
[125] B. Singh,et al. Arrhythmia control by prolonging repolarization: the concept and its potential therapeutic impact. , 1993, European heart journal.
[126] K. Minneman,et al. Interaction of neuronal nitric oxide synthase with alpha1-adrenergic receptor subtypes in transfected HEK-293 cells , 2002, BMC pharmacology.
[127] Mark T. Gladwin,et al. The nitrate–nitrite–nitric oxide pathway in physiology and therapeutics , 2008, Nature Reviews Drug Discovery.
[128] J S Floras,et al. Sympathetic activation in human heart failure: diverse mechanisms, therapeutic opportunities. , 2003, Acta physiologica Scandinavica.
[129] J. Bigger,et al. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction , 1998, The Lancet.
[130] S. Ellis,et al. Inhibitory effect of acetylcholine on glycogenolysis in the isolated guinea-pig heart. , 1963, The Journal of pharmacology and experimental therapeutics.
[131] E. Angelakos. Regional Distribution of Catecholamines in the Dog Heart , 1965, Circulation research.
[132] J. Armour,et al. Ventricular arrhythmias induced by chemically modified intrinsic cardiac neurones. , 1994, Cardiovascular research.
[133] H. Critchley,et al. Heart–brain interactions in cardiac arrhythmia , 2011, Heart.
[134] T. Seeman,et al. RR Interval Variability Is Inversely Related to Inflammatory Markers: The CARDIA Study , 2007, Molecular medicine.
[135] M D Gershon. The enteric nervous system. , 1981, Annual review of neuroscience.
[136] Brian Olshansky,et al. Parasympathetic nervous system and heart failure: pathophysiology and potential implications for therapy. , 2008, Circulation.
[137] R. Verrier,et al. The Effect of Vagus Nerve Stimulation upon Vulnerability of the Canine Ventricle: Role of Sympathetic‐Parasympathetic Interactions , 1975, Circulation.
[138] R. Prescott,et al. Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-heart). , 1998, Circulation.
[139] Hani N. Sabbah,et al. Electrical vagus nerve stimulation for the treatment of chronic heart failure , 2011, Cleveland Clinic Journal of Medicine.
[140] S. Pogwizd,et al. Connexin 43 Downregulation and Dephosphorylation in Nonischemic Heart Failure Is Associated With Enhanced Colocalized Protein Phosphatase Type 2A , 2004, Circulation research.
[141] A. Kadish,et al. Quantitative analysis of parasympathetic innervation of the porcine heart. , 2010, Heart rhythm.
[142] F. Murad,et al. Adenyl cyclase. III. The effect of catecholamines and choline esters on the formation of adenosine 3',5'-phosphate by preparations from cardiac muscle and liver. , 1962, The Journal of biological chemistry.
[143] H. L. Stone,et al. Baroreceptor Reflex Control of Heart Rate: A Predictor of Sudden Cardiac Death , 1982, Circulation.
[144] E. Braunwald,et al. Parasympathetic control of the heart. , 1973, Pharmacological reviews.
[145] L. Tavazzi. Heart rate as a therapeutic target in heart failure , 2003 .
[146] Yanjie Lu,et al. Function of cardiac M3 receptors. , 2007, Autonomic & autacoid pharmacology.
[147] Kevin J. Tracey,et al. Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammation , 2002, Nature.